Trial intelligence / Profile preview

High vs Standard Dose PPIs for Bleeding Peptic Ulcers

NCT00374101Phase 3Completed

Sponsor
Casa Sollievo della Sofferenza
Start
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of omeprazole, pantoprazole in peptic ulcer disease (PUD), upper gastrointestinal bleeding (UGIB), sponsored by Casa Sollievo della Sofferenza. Started Jan 2005; status: completed.

02

Drugs

omeprazolepantoprazole
03

Conditions

peptic ulcer disease (PUD)upper gastrointestinal bleeding (UGIB)

Beyond the preview

Go deeper on NCT00374101.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00374101.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call